ANXA2 and neoplasm: In hepatocellular carcinoma (HCC), ANXA2 overexpression correlates with tumor aggressiveness and metastasis, influencing cancer progression by regulating the extracellular matrix and promoting tumor cell migration and invasion (49, 50).